Crispr Genetic Screens
Crispr Genetic Screens - Related Videos
08:50
Genetic Screens
0 Views •
2023
Genetic screens are critical tools for defining gene function and understanding gene interactions. Screens typically involve mutating genes and then assessing the affected organisms for phenotypes of interest. The process can be “forward”, where mutations are generated randomly to identify unknown genes responsible for the phenotypes, or it can be “reverse”, where specific genes are targeted for mutation to observe what phenotypes are produced.Here, JoVE reviews various types of genetic...
02:46
Genetic Screens
0 Views •
2021
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options. Forward genetic screens Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
00:09
Pooled CRISPR-Based Genetic Screens in Mammalian Cells
0 Views •
Cited by 14 •
2019
CRISPR-Cas9 technology provides an efficient method to precisely edit the mammalian genome in any cell type and represents a novel means to perform genome-wide genetic screens. A detailed protocol discussing the steps required for the successful performance of pooled genome-wide CRISPR-Cas9 screens is provided here.
02:55
Genetically Modifying CAR T Cells Using a CRISPR-Cas9 System
0 Views •
2025
The video outlines a process for creating genetically modified CAR T cells through the CRISPR-Cas9 System. Infecting T cells with CRISPR and CAR lentiviruses results in modifications to the target gene and the synthesis of a chimeric antigen receptor or CAR, ultimately leading to the formation of genetically modified CAR T cells.
08:10
Multi-enzyme Screening Using a High-throughput Genetic Enzyme Screening System
0 Views •
Cited by 7 •
2016
This work presents a method of high-throughput screening using a universal genetic enzyme screening system that can be theoretically applied to over 200 enzymes. Here, the single screening system identifies three different enzymes (lipase, cellulase, and alkaline phosphatase) by simply changing the substrate used (p-nitrophenyl acetate, p-nitrophenyl-β-D-cellobioside, and phenyl phosphate).
FAQs
Guide-enrichment patterns connect a perturbation to the measured phenotype by showing how targeted genetic changes differ after the experimental condition. Researchers compare these patterns across the screened population to prioritize genes that influence survival or another measured trait. This converts many individual guide effects into a ranked set of candidate genetic regulators for further study.
The perturbation mode determines what kind of genetic question the screen can address. CRISPR-associated proteins can be directed to disrupt a gene, repress its activity, or activate it, allowing researchers to examine loss-of-function and changes in gene activity within the same broad screening framework. Selecting among these modes helps connect a candidate gene with the type of phenotype observed.
Pooled formats make scale a central advantage: many guide-directed perturbations can be tested in parallel across a large cell population rather than examined one at a time. This design supports systematic comparison of thousands of genetic targets under a shared experimental condition. The resulting screen can reveal broad patterns of gene influence that would be difficult to obtain from isolated experiments.
A typical workflow begins with guide RNAs directing CRISPR-associated proteins toward selected genomic targets. Researchers then expose the perturbed cells to a condition, measure survival or another phenotype, and examine guide-enrichment patterns. Candidate genes identified from this first pass require follow-up experiments, which validate the candidates and clarify whether the observed relationship is causal.
CRISPR genetic screens are useful when the goal is to discover many genetic contributors to a biological response at once. Supported applications include mapping disease mechanisms, identifying genes associated with drug resistance, finding essential genes, and examining host-pathogen interactions. Because numerous targets can be surveyed together, the approach helps generate candidate gene sets for focused studies of a particular condition.
In genetics, these screens connect gene perturbations with phenotypic outcomes at pathway scale. A survival change or other measured effect can point to genes that influence a biological process, but the initial association does not by itself explain the mechanism. Follow-up validation is therefore important for separating promising candidates from relationships needing clarification and for building a more defensible causal model.